Akari Therapeutics (AKTX) announced the appointment of Kameel Farag as its Interim Chief Financial Officer who joined Akari last month. Farag joins Akari after having most recently served as Chief Financial Officer and head of business operations at Aspen Neuroscience
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX: